CWM
TMO icon

Confluence Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Confluence Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$1.71M Buy
5,866
+507
+9% +$209K 0.84% 27
2020
Q2 		$1.94M Sell
5,359
-239
-4% -$80.1K 0.92% 28
2020
Q1 		$1.59M Sell
5,598
-181
-3% -$57.1K 0.89% 30
2019
Q4 		$1.88M Sell
5,779
-87
-1% -$26.4K 0.87% 26
2019
Q3 		$1.71M Sell
5,866
-239
-4% -$68.4K 0.84% 27
2019
Q2 		$1.79M Sell
6,105
-273
-4% -$75.2K 0.88% 21
2019
Q1 		$1.75M Sell
6,378
-638
-9% -$159K 0.87% 22
2018
Q4 		$1.57M Buy
7,016
+147
+2% +$34.5K 0.88% 27
2018
Q3 		$1.68M Sell
6,869
-185
-3% -$42.6K 0.87% 26
2018
Q2 		$1.46M Sell
7,054
-30
-0.4% -$6.37K 0.77% 31
2018
Q1 		$1.46M Sell
7,084
-754
-10% -$158K 0.75% 27
2017
Q4 		$1.49M Sell
7,838
-932
-11% -$179K 0.71% 30
2017
Q3 		$1.66M Sell
8,770
-152
-2% -$27.5K 0.81% 24
2017
Q2 		$1.56M Buy
8,922
+38
+0.4% +$6.38K 0.74% 29
2017
Q1 		$1.36M Sell
8,884
-1,538
-15% -$235K 0.67% 32
2016
Q4 		$1.47M Sell
10,422
-52
-0.5% -$7.67K 0.74% 28
2016
Q3 		$1.67M Sell
10,474
-329
-3% -$50.7K 0.81% 26
2016
Q2 		$1.6M Sell
10,803
-2,115
-16% -$312K 0.79% 28
2016
Q1 		$1.83M Sell
12,918
-262
-2% -$35.1K 0.83% 28
2015
Q4 		$1.87M Sell
13,180
-454
-3% -$60.6K 0.91% 29
2015
Q3 		$1.67M Buy
13,634
+445
+3% +$58K 0.9% 28
2015
Q2 		$1.71M Sell
13,189
-32
-0.2% -$4.17K 0.94% 25
2015
Q1 		$1.78M Sell
13,221
-1,504
-10% -$194K 1.03% 21
2014
Q4 		$1.84M Sell
14,725
-1,567
-10% -$191K 1.15% 18
2014
Q3 		$1.98M Sell
16,292
-431
-3% -$52.4K 1.34% 15
2014
Q2 		$1.97M Sell
16,723
-143
-0.8% -$16.8K 1.12% 18
2014
Q1 		$2.03M Buy
+16,866
New +$2.01M 1.53% 11

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Confluence Wealth Management's TMO Position: Q3 2020 in Review

Confluence Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 9.5% in Q3 2020, buying an estimated $209K and bringing the position to 5,866 shares worth $1.71M. The position accounts for 0.84% of the portfolio, ranked #27.

Confluence Wealth Management first reported a position in TMO in Q1 2014 and has held it in 27 quarters since. The position peaked at $2.03M in Q1 2014. 1,847 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

  • Confluence Wealth Management held 5,866 shares of Thermo Fisher Scientific worth $1.71M as of Q3 2020.
  • Confluence Wealth Management bought 507 Thermo Fisher Scientific shares in Q3 2020, an estimated $209K.
  • Thermo Fisher Scientific made up 0.84% of Confluence Wealth Management's portfolio in Q3 2020, its #27 holding.
  • Confluence Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 27 quarters since.
  • Confluence Wealth Management's Thermo Fisher Scientific position peaked at $2.03M in Q1 2014.
  • 1,847 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on Confluence Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.